Episode Details
Back to Episodes
Pfizer Q4 2025 Earnings: Obesity Pipeline and Financial Performance
Published 6 months ago
Description
Pfizer’s 2026 strategy focuses on Oncology, Obesity, and R&D milestones. Key priorities include advancing ADCs, monthly GLP-1 candidates, and achieving $7.2B in net cost savings. The firm aims for long-term growth through AI integration and strategic acquisitions.